Today on in-pharmatechnologist.com   April 1 cut off-for cold and flu meds India can dominate global pharma landscape Antares lands fourth Teva deal Millipore promises pure biologics Contract manufacturing news in brief

Related Industry News   Superbug test approved, cuts days off MRSA diagnosis Animal activists hamper Dutch science park construction WuXi PharmaTech makes its first acquisition Galapagos scores first oncology contract

		In association with
Breaking News on Pharmaceutical Technology
Daily  Tuesday 08 January 2008		Forward to a colleague

	Sponsored Link Oncological API Specialist ScinoPharm, specialized in manufacturing cGMP grade oncological APIs, offers fully integrated services to develop and manufacture final APIs capabilities including process research and development, analytical development and regulatory submission... Click Here Access Full Stories April 1 cut off-for cold and flu meds Pharmacies in the UK would indeed be foolish to ignore new restrictions on nasal decongestants that will become law as of April 1, 2008... Read India can dominate global pharma landscape Although India 'has carved out a significant portion of the world pharma pie', an enormous change in mindset is needed if the country is to become a global pharmaceutical hub, according to a new report from KPMG... Read Antares lands fourth Teva deal Drug delivery specialist Antares Pharma has landed its fourth deal with Israeli generics behemoth Teva, this time to develop a novel pen injector for two Teva products... Read Millipore promises pure biologics Millipore has announced the first fruit of its collaboration with testing specialist Gen-Probe, with the launch of a new contaminant detection system for biopharmaceutical manufacturers... Read Contract manufacturing news in brief Pfizer, Hyaluron Contract Manufacturing and DSM have all recently generated new contract manufacturing news... Read
	All News Headlines for: January | December | November
	Seminar Info Premier event for excipient manufacturers and end-users Europe's only dedicated forum on issues affecting the excipients sector is just two months away. Don't miss your chance to hear the latest on key topics such as supply chain integrity, counterfeiting, excipient master files and REACH... Click Here
	Related Industry News Superbug test approved, cuts days off MRSA diagnosis Numerous lives could be saved by a new blood test that can identify MRSA within two hours, instead of as many days, following its approval by the US Food and Drug Administration (FDA)... Read Animal activists hamper Dutch science park construction A Dutch developer has pulled out of a €60m project to build a science park in the country after it was "continually confronted" by animal rights extremists... Read WuXi PharmaTech makes its first acquisition WuXi PharmaTech, China's contract research titan, has orchestrated its first acquisition, gaining biologics capabilities and a base in the US... Read Galapagos scores first oncology contract Galapagos' services arm has scored another lucrative contract from big pharma - its first in the field of oncology - as it continues to broaden its experience... Read Annual round up of all drugs entering Phase I Small molecules still leading the way into the clinic DrugResearcher.com brings you its annual round up of all the drugs that entered clinical development in 2007. Read Product Brochure Tablet Design: A Critical Aspect of Product Development Good tablet design can provide manufacturers with a unique product and helps to ensure optimum productivity, avoiding premature tooling wear and failure. For further information... Click Here Previous Headlines Crucell, Sanofi mix it up with rabies cocktail deal Dutch firm Crucell last week announced that it has entered into an agreement with vaccine specialist Sanofi Pasteur for its next generation rabies antibody cocktail... Read Warding off the generic attack A recent report has detailed the challenges facing the pharma industry as the generic flood gates open, with the constant advice to start planning early still apparently not heeded by a bewildering number of firms... Read Drug industry spend twice as much on marketing as on R&D The pharma industry spends almost twice as much promoting its drugs as it does trying to develop them, according to a new study... Read Model checks out how biosensors shape up A group of US researchers have developed a new computer model to study and design miniature biosensors, which could help life scientists perfect lab-on-a-chip technology... Read FDA approval for Skye, Sciele blood pressure med Despite a two month extension of the PDUFA date by the US Food and Drug Administration (FDA), Sciele and SkyePharma this week announced the approval of their controlled release formulation of high blood pressure... Read Technical / White Papers, Case studies, Web casts Shop floor integration at Novartis Singapore - Case Study Manufacturing Execution Systems to Optimize the Pharmaceutical Supply Chain - Technical / White Paper Product Information - brochures, Web centers Transdermal Sufentanil Licensing Opportunity - Application Notes Reproducible, homogeneous dry dispersions by the Morphologi® - Application Notes A Review of Dissolution tests with the Flow Through Method - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Cleanroom, safety equipment, supplies Contract services (outsourcing) Drug delivery systems Ingredients, excipients and raw materials IT solutions Lab equipment & consumables Packaging machinery & supplies Processing (automation, control, separation...) QA/QC & validation Tabletting, coating & ancillary equipment

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com